Investment Criteria

KBA will consider investment opportunities in the following areas and technologies:

Infographic Icon

The innovation is in one of these three industry sectors: Agribusiness, Animal Health or Human Health.

Infographic Icon

The company has a disruptive technology.

Infographic Icon

There is a compelling market opportunity and clear competitive advantage.

Infographic Icon

The right management team is in place to carry the innovation through.

Infographic Icon

There is a clear exit strategy for investors.

Infographic Icon

The innovation is in one of these three industry sectors: Agribusiness, Animal Health or Human Health.

Infographic Icon

There is a compelling market opportunity and clear competitive advantage.

Infographic Icon

The company has a disruptive technology.

Infographic Icon

The right management team is in place to carry the innovation through.

Infographic Icon

There is a clear exit strategy for investors.

Infographic Icon

The innovation is in one of these three industry sectors: Agribusiness, Animal Health or Human Health.

Infographic Icon

The company has a disruptive technology.

Infographic Icon

There is a compelling market opportunity and clear competitive advantage.

Infographic Icon

The right management team is in place to carry the innovation through.

Infographic Icon

There is a clear exit strategy for investors.

Sector Focus

Agribusiness

AGRIBUSINESS

KBA seeks to invest in disruptive technologies in agriculture, crop science and and crop-derived products that provide a safe and reliable protein source to a growing global population.

Learn More

Animal Health

ANIMAL HEALTH

KBA invests in production and companion animal technologies and product innovations. KBA seeks to invest in production animal technologies that help address the growing global demand for safe, reliable and affordable sources of protein.  KBA looks for innovation in companion animal health that bring novel therapies to pets and helps improve the range of care options available for companion animals. 

Learn More

Bioenergy

HUMAN HEALTH

Kansas’ robust human health sector includes global leaders in research, drug and device development, clinical care, healthcare IT and engineering. KBA seeks investments in new medical devices and diagnostics, healthcare IT and mobile health as well as drug development and delivery with relatively short exits in areas that protect and advance human health.

Learn More

Success Stories

Success Story Logo

Aratana Therapeutics Inc. (NASDAQ:PETX) in-licenses compounds developed for human health and then develop and commercialize them as regulatory-approved therapeutics for companion animals. Aratana’s model allows it to move quickly, developing animal health pharmaceutical technologies at competitively lower costs to serve the unmet need of products approved to specifically manage pets’ health safely and effectively.

Learn More

Success Story Logo

Green Dot Holdings develops, commercializes, manufactures and distributes proprietary biodegradable and compostable biopolymer resins as a substitute for non-biodegradable, petroleum-based plastics. It produces the only organic, compostable, soft and flexible elastomer in the world that is ASTM and EU certified for biodegradability and compostability. Most biopolymer competitors offer a more rigid and brittle product which can only be used in hard applications.

Learn More

Success Story Logo

Health Outcomes Sciences’ clinical decision support ePRISM® technology helps healthcare institutions reduce the complication rates from procedures, improves patient satisfaction and enables hospitals to better allocate expensive medical resources to patients who need them most. HOS has an exclusive partnership with the American College of Cardiology to translate the ACC risk models to clinical care.

Learn More

Venture Accelerator

The Venture Accelerator is a 39,000-square-foot, Gold LEED-certified facility custom designed to serve emerging bioscience organizations looking to successfully take their discoveries to market.

Situated in the Kansas Bioscience Park in Olathe, incubator tenants have access to bioscience expertise and research excellence, wet labs and state-of-the-art amenities, all tailored to accelerate the commercialization of bioscience innovations.

The Kansas Bioscience Park is a 92-acre development designed to serve local, regional, national or multi-national bioscience organizations looking to grow their operations within the thriving KC Animal Health Corridor. Land is available at no cost to bioscience companies.

Working With Us

Each KBA investment team member brings years of experience from one or more of the three sectors, have raised capital, participated in the management of invested companies, and not only taken them to successful rounds of additional funding but to commercialization, IPO or sale.

For the investment team and the entrepreneur, it can be a long, close collaboration where KBA works alongside the entrepreneur to nurture the innovation, give management guidance and do all in their power to get the product to market.

A phone call gets the conversation started. It is best to be prepared with an investment deck or overview that addresses the problem, the unmet need and competitive marketplace, IP protection in place, the management team, previous investment and funding needed.